Related Experiment Video
Updated: May 1, 2026

Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
Right heart failure post left ventricular assist device implantation
Mihalis Argiriou1, Styliani-Maria Kolokotron1, Timothy Sakellaridis1
11 Cardiac Surgery Department, Transplantation Unit, "Evangelismos" Hospital, Athens, Greece ; 2 University of Ioannina School of Medicine, Ioannina, Greece ; 3 Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece ; 4 Surgery Department (NHS), University General Hospital of Alexandroupolis, Alexandroupolis, Greece ; 5 Internal Medicine Department, Theageneio Anticancer Hospital, Thessaloniki, Greece ; 6 Cardiothoracic Surgery Department, "Saint Luke" Private Hospital, Panorama, Thessaloniki, Greece.
Abstract:
Right heart failure (RHF) is a frequent complication following left ventricular assist device (LVAD) implantation. The incidence of RHF complicates 20-50% (range, 9-44%) of cases and is a major factor of postoperative morbidity and mortality. Unfortunately, despite the fact that many risk factors contributing to the development of RHF after LVAD implantation have been identified, it seems to be extremely difficult to avoid them. Prevention of RHF consists of the management of the preload and the afterload of the right ventricle with optimum inotropic support. The administration of vasodilators designed to reduce pulmonary vascular resistance is standard practice in most centers. The surgical attempt of implantation of a right ventricular assist device does not always resolve the problem and is not available in all cardiac surgery centers.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure VI: Adjunct Therapies
Heart Failure III: Clinical Manifestations
Heart Failure IV: Classification and Diagnostic Evaluation
Cardiac Catheterization II: Right Heart Catheterization

